Cardiovascular Outcomes in Patients with Normal and Abnormal 24-Hour Ambulatory Blood Pressure Monitoring
Table 2
Comparison of cohorts 1 and 2.
Cohort 1: 1187 patients
Cohort 2: 245 patients
Statistical significance
Age
59.13 yrs ± 13.9
60.1 yrs ± 13.6
NS
N
%
N
%
Male
547
46.1
107
43.7
NS
Female
640
53.9
138
56.3
Adverse features
N
%
N
%
High PP ≥ 50 mmHg
736
62.0
161
65.7
NS
High DSBP ≥ 135 mmHg
703
59.2
146
59.6
NS
High DDBP ≥ 85 mmHg
515
43.4
101
41.2
NS
High NSBP ≥ 120 mmHg
639
54.0
138
56.3
NS
High NDBP ≥ 75 mmHg
404
34.0
83
33.9
NS
Absent ND ≤ 10%
677
57.0
134
54.7
NS
High EM SBP ≥ 140 mmHg
396
33.4
74
30.2
NS
High MS ≥ 20/15 mmHg
552
46.5
106
43.3
NS
No. adverse features
N
%
N
%
NS
0
63
5.3
13
5.3
NS
1
114
9.6
22
9.0
NS
2
177
14.9
35
14.3
NS
3
168
14.2
43
17.6
NS
4
176
14.8
35
14.3
NS
5
182
15.3
37
15.1
NS
6
151
12.7
30
12.2
NS
7
119
10.0
23
9.4
NS
8
37
3.1
7
2.9
NS
Adverse Features groups
N
%
N
%
0–2
354
29.8
70
28.6
3–5
526
44.3
115
46.9
NS
6–8
307
25.9
60
24.5
There was no significant difference between the two cohorts. (Oneway Anova was used for comparing cohort 1 and 2 ages; cross-tabulation with chi-square Test was used to compare adverse features; no. of adverse features and adverse features groups and gender).
